Radio Rare

Radio Rare

By Rare Cancers AustraliaBusinessNon-Profit
Download on the App Store

Radio Rare episodes

  • ABC Radio interview with RCA CEO, Christine Cockburn

    Our CEO, Christine Cockburn, caught up with James Valentine recently on ABC Radio.

    They chatted about James’s own experience with cancer, Oesophageal Cancer Awareness Month, and the devastating inequities facing people diagnosed with rare or less common cancers. 

    26 min
  • Sarah McGoram, a rare cancer patient, will be climbing Australia's tallest mountain as part of Rare Cancer Australia's Kosi Challenge.

    Every year, more than 40,000 Australians are diagnosed with some form of rare cancer. And for those who are, treatments can be hard to find. And they can be expensive if you can get them.  Sarah McGoram knows this firsthand. 

    She was diagnosed with a rare cancer at just 18 years of age, and still lives with it today. This weekend, Sarah will climb Australia's tallest mountain as part of Rare Cancer Australia's Kosi Challenge.


    19 min
  • The Australian genomic landscape and what we can learn from others | Policy Roundtable Series

    Rare Cancers Australia and Australian Genomics invite you to a policy roundtable series exploring the enablers and barriers to genomic-led cancer care for people diagnosed with rare, less common and complex cancers.
    Your valuable perspective will contribute to discussions and a report, with practical recommendations for accelerating equitable access to genomic-led cancer care in Australia. Hear from experts in the field and share your own ideas, challenges and opportunities.

    28 min
  • RCA CEO, Christine Cockburn, interviewed with i98 Power FM radio on the need for a pan-tumour approach to cancer care

    People living with cancer urgently need action on expanded access to precision therapies

    Over the past two decades, our ability to rapidly obtain genomic information on an individual and their cancer has led to a dramatic shift in how we can diagnose, treat, monitor and prevent cancer, leading to an era of precision oncology.

    With this expanded knowledge of cancer there are several promising treatments that can specifically target the drivers of an individual’s cancer, that are already under review through Australia’s health technology assessment process. Too many people living with cancer in Australia still don’t have access; and they can’t afford to wait.

    6 min
  • What happens when you are diagnosed with a rare cancer?

    In this edition of The Conversation Hour, hosted by ABC Radio Melbourne, we hear the experiences of callers who have been diagnosed with a rare cancer and their families. We also learn about the latest developments in treatment and support with guests Professor Clare Scott who is a clinician scientist, leading the ovarian and rare cancer laboratory at WEHI and Danielle Spence from the Cancer Council Victoria.


    Credits

    Richelle Hunt, Presenter


    All rights belong to ABC Radio Melbourne.

    51 min
  • Thought Leader Series: Thinking big, how we can make a difference for patients, Professor Grant McArthur

    Professor Grant McArthur

    Executive Director, VCCC Alliance
    Head of the Molecular Oncology Lab, Peter Mac

    Thinking big: how we can make a difference for patients

    In this episode, RCA Chief Executive Richard Vines speaks to Professor Grant McArthur about:

    · The challenges of personalising cancer treatment

    · How the moon landing sparked a career in medicine

    · Why he chose to specialise in cancer, and melanoma

    · What gets him out of bed in the morning, and what drives him

    · The vision of the VCCC, and how it came about

    · Why he moved from a full-time research and clinical role to a leadership position

    · The sensitivities around prescribing medications that are not PBS funded

    · The gaps between published evidence, TGA approval and PBS listing

    · Ideas on how to speed up patient access to life-extending and life-saving treatment

    · The challenges and opportunities of developing combination treatments

    · How we can continue to improve cancer outcomes in the next 10 years

    More about Professor Grant McArthur

    Grant is the Executive Director of the VCCC Alliance, a powerful partnership of 10 leading research, academic and clinical institutions, working together to fundamentally reshape the way we tackle cancer. Grant is also Head of the Molecular Oncology Lab at the Peter MacCallum Cancer Centre, and a highly cited melanoma researcher.

    30 min
  • Thought Leader Series: The future of cancer and medical research, Emeritus Professor Ian Frazer
    Emeritus Professor Ian Frazer
    University of Queensland
    The future of cancer and medical research

    In this episode, RCA Chief Executive Richard Vines speaks to Professor Ian Frazer about:

    • Inventing the technology behind the world’s first cancer vaccine
    • Vaccine hesitancy, and the potential of other vaccines for cancer
    • What makes the Translational Research Institute so special
    • The interface between clinicians, scientists and patients in medical research
    • Our expanding understanding of cancer and targeted treatment
    • The experience of being Australian of The Year, and what he’s working on now
    • How the Medical Research Future Fund works
    • The alleged brain drain of medical researchers from Australia
    • The need to better embed medical research into the health system
    • How he sees medical research benefiting patients in 10 years’ time
    • More about Emeritus Professor Ian Frazer

      Ian and his colleague co-invented the technology behind the world’s first cervical cancer vaccine.

      He is the founding CEO of the Translational Research Institute in Brisbane, heads a biotechnology company working on new vaccine technologies, and chairs the advisory board of the Medical Research Future Fund.

      30 min
    • Thought Leader Series: Improving the patient voice in the Australian health system, Ann Single

      Ann Single

      Patient Voice Initiative

      Improving the patient voice in the Australian health system

      In this episode, RCA Chief Executive Richard Vines speaks to Ann Single about:

      - The limitations of Australia’s Health Technology Assessment (HTA) process

      - How and why the HTA process needs to be framed from a patient perspective
      - Australia’s perception of ‘value’ as it applies to health versus other areas like defense
      - The need to embrace uncertainty and speed up patient access to cancer treatments
      - Why she finds HTA fascinating and why she’s optimistic about the HTA Review
      - What she’s learned from 20 years of working with patients
      - Improving the patient voice in the Australian health system
      - Why she moved from journalism to science communication

      More about Ann Single

      Ann is Coordinator of the Patient Voice Initiative, an association that works towards improving the patient voice in the Australian health system. She has more than 20 years of experience in developing policy and practice in patient involvement in health technology assessment, or HTA. Ann is Chair of the HTAi Interest Group for Patient and Citizen Involvement in HTA and has been selected as a consumer representative on the Australian Government’s HTA review.

      31 min

    About Radio Rare

    From the publisher's feed

    Radio Rare is a podcast where we share the stories of those in and around the rare and less common cancer community.

    More shows like Radio Rare

    Bronwyn by The Australian

    Bronwyn

    301 Listeners